3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
148
Breast Neoplasms
112
Prostatic Neoplasms
61
Neoplasms
56
Multiple Myeloma
55
Lung Neoplasms
50
Neoplasm Metastasis
43
Ovarian Neoplasms
34
Colorectal Neoplasms
33
Parkinson Disease 4, Autosomal Dominant Lewy Body
31
Leukemia, Lymphocytic, Chronic, B-Cell
31
Leukemia, Myeloid, Acute
26
Carcinoma, Renal Cell
26
Recurrence
25
Urinary Bladder Neoplasms
23
Small Cell Lung Carcinoma
22
Myasthenia Gravis
22
Carcinoma, Hepatocellular
22
Triple Negative Breast Neoplasms
21
Lymphoma, Large B-Cell, Diffuse
21
Endometrial Neoplasms
21
Squamous Cell Carcinoma of Head and Neck
19
Melanoma
18
Lymphoma, Follicular
18
Nasopharyngeal Carcinoma
17
Fallopian Tube Neoplasms
16
Stomach Neoplasms
15
Pancreatic Neoplasms
15
Non-Muscle Invasive Bladder Neoplasms
15
Lymphoma, Non-Hodgkin
15
Interventions
BIVV001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Coagulation Protein Disorders
×
90 days
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled